1-3 of 3
Gerhard Woolthuis, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall Survival Patterns in Patients with Multiple Myeloma in the Era of Novel Agents and the Role of Initial Clinical Presentation and Comorbidities: A Population-Based Study

Berdien Oortgiesen, Eric N. van Roon, PharmD, PhD, Peter Joosten, MD, Robby Kibbelaar, MD PhD, Huib Storm, PhD, Sjoerd Hovenga, MDPhD, Bas P Van Rees, MD PhD, Gerhard Woolthuis, MD, Nic J.G.M. Veeger, PhD, Mels Hoogendoorn, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2136.
https://doi.org/10.1182/blood.V124.21.2136.2136
Published: 2014
Journal Articles

Combined Treatment of Bortezomib, Continuous Low-Dose Cyclophosphamide and Dexamethasone Followed By One Year of Maintenance Treatment for Refractory or Relapsed Multiple Myeloma Patients: A Prospective Phase II Study

Esther GM Waal de, MD, Linda Munck de, Gerhard Woolthuis, MD, Annet velden Van Der, MD, Yvonne Tromp, MD, Mels Hoogendoorn, MD PhD, Edo Vellenga, MD PhD, Sjoerd Hovenga, MDPhD
Journal: Blood
Blood (2014) 124 (21): 4733.
https://doi.org/10.1182/blood.V124.21.4733.4733
Published: 2014
Journal Articles

A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome.

Karin Boslooper, Peter Joosten, MD, Nic J.G.M. Veeger, PhD, Robby Kibbelaar, MD, PhD, Eric van Roon, Sjoerd Hovenga, Gerhard Woolthuis, MD, Hanneke C. Kluin-Nelemans, Mels Hoogendoorn, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2642.
https://doi.org/10.1182/blood.V120.21.2642.2642
Published: 2012